Korea Seeks Two-Track Strategy For COVID-19 Drugs, Vaccines
Moves To Secure Foreign Supplies If Necessary
Executive Summary
As a recent increase in silent virus spreaders in metropolitan areas raises concerns, South Korea unveils policy measures to support the development of COVID-19 drugs and vaccines, as well as to secure imports of such products if necessary.
You may also be interested in...
Korea To Keep Tight Policy Focus On COVID-19 This Year
South Korea is ramping up policy and financial support in its continuing efforts to control COVID-19, with new drugs and vaccines set to benefit amid broader infectious disease control measures.
Celltrion Progresses COVID-19 Antibody Therapeutic, Pricing Will Be Key
Celltrion presses ahead with Phase I study of COVID-19 antibody therapeutic, encouraged by the support of the South Korean government. The firm also urges global cooperation to lower prices of COVID-19 drugs and vaccines to end the global pandemic.
New Korean Accounting Guidelines Aim For More Flexible Biopharma Practices
South Korea moves to lay out clearer accounting guidelines related to R&D costs for pharma and biotech companies, making improvements to earlier official guidance in 2018 in order to ease uncertainties and help foster the sector.